CureVac (5CV.F) Stock Price

€3.29 0%

Sign up
to add to portfolio

AI Score

Hold
  • Alternative

    3
  • Fundamental

    8
  • Technical

    5

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on CureVac, AI stock picks, stock alerts and much more.

Sign up

5CV.F AI Stock Analysis

AI stock analysis for 5CV.F is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like CureVac (5CV.F) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

CureVac (5CV.F) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of CureVac (5CV.F), currently trading at €3.29, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About 5CV.F

LSE

Similar Stocks

22UA.F BioNTech SE
22UA.F
€82.45
0.6%
6
NVV1.F Novavax
NVV1.F
€6.04
7.3%
2
HPHA.DE Heidelberg Pharma AG
HPHA.DE
€3.23
0.9%
5
FYB.DE Formycon AG
FYB.DE
€22.9
0.2%
4
BNN.DE BRAIN Biotech AG
BNN.DE
€2.12
1%
4

5CV.F Alternative Data

Web Traffic

CureVac receives an estimated 29526 monthly visitors to curevac.com.

  • Web Traffic

    29526

  • Change from Previous Month

    32.4%

  • 3 Month Change

    30%

  • YoY Change

    30%

Twitter Followers

CureVac has 18,587 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.5% over the last month.

  • Twitter Followers

    18587

  • Daily Change

    0%

  • 1 Month Change

    0.5%

  • 3 Month Change

    1.4%

  • YoY Change

    1.4%

Youtube Subscribers

CureVac has 616 subscribers on its main Youtube channel.

  • Youtube Subscribers

    616

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0.2%

Job Postings

CureVac has an estimated 4 open job postings, which is down -55.6% over the last month.

  • Job Postings

    4

  • Daily Change

    0%

  • 1 Month Change

    55.6%

  • 3 Month Change

    73.3%

Reddit Mentions

CureVac has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

LinkedIn Followers

54,194 are following CureVac on LinkedIn, up by 0.3% over the last month.

  • LinkedIn Followers

    54194

  • Daily Change

    0.3%

  • 1 Month Change

    0.3%

  • 3 Month Change

    1.6%

  • YoY Change

    1.6%

LinkedIn Employees

According to LinkedIn, CureVac has 721 employees, down by -2.4% over the last month.

  • LinkedIn Employees

    721

  • Daily Change

    2.4%

  • 1 Month Change

    2.4%

  • 3 Month Change

    3.9%

  • YoY Change

    3.9%

News Mentions

CureVac was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

Business Outlook

According to employee reviews, the business outlook among employees at CureVac is 28 out of 100 (bearish).

  • Business Outlook

    28

  • Change from Previous Month

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

5CV.F Financials

5CV.F Key Metrics
  • Total Revenue

    €14.5M

  • Net Income

    -€32.8M

  • Earnings per Share

    -€0.15

  • Free cash flow

    -€69.1M

  • EBITDA

    -€34.9M

  • EBITDA Ratio

    -2.41157

  • Total Assets

    €802.8M

5CV.F 2-year Revenue & Income
5CV.F 2-year Free Cash Flow

5CV.F Technicals

5CV.F SMA
5CV.F RSI

FAQ

What's the current price of CureVac (5CV.F) Stock?
The price of an CureVac (5CV.F) share is €3.29.

What's the market cap of CureVac?
The current market cap of CureVac is 741.7M.

Should I buy or sell 5CV.F?
CureVac shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, CureVac is better viewed as a hold or accumulate position while waiting for further developments.

Is CureVac a good investment?
The current analysis of CureVac's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in CureVac's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy CureVac (5CV.F) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for CureVac stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to CureVac (5CV.F) that investors often compare it to?
CureVac (5CV.F) is often compared to similar stocks such as BioNTech SE, Novavax, Heidelberg Pharma AG, Formycon AG and BRAIN Biotech AG.

What is the forecast for CureVac's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast CureVac's stock price to be around €3.24 in 2026. Starting from the current price of €3.29, this represents a 1.6% change in price, indicating a neutral outlook for the stock.

How to buy CureVac (5CV.F) Stock?
CureVac stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy CureVac shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.